Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:49:09 UTC |
---|
HMDB ID | HMDB0001247 |
---|
Secondary Accession Numbers | - HMDB0015456
- HMDB01247
- HMDB15456
|
---|
Metabolite Identification |
---|
Common Name | Aluminum |
---|
Description | Aluminum is a soft, lightweight metal with an appearance ranging from silvery to dull gray, depending on the surface roughness. Data indicate that aluminum contaminates much of the raw material used to manufacture solutions used for intravenous nutritional support of hospitalized and ambulatory patients, and that pharmaceutical manufacturers have only recently obtained the technology necessary to detect aluminum contamination of their products. As a result, aluminum bypassed normal barriers and entered the blood, accumulating in bone, the liver, and the central nervous system with toxic consequences. Now that the FDA has finally issued a rule governing aluminum contamination in these solutions, manufacturers will need to develop methods to minimize such contamination. Scientists should also realize that when the data they obtain indicate a serious problem in the manufacturing sector, they should be sure that the problem is properly addressed. Physiologically, this metal/element exists as an ion in the body (PMID: 16198633 ). Aluminum acetate is an astringent. An astringent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application. The shrinkage or constriction is through the osmotic flow of water (or other fluids) away from the area where the astringent was applied. Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete's foot. |
---|
Structure | |
---|
Synonyms | Value | Source |
---|
13Al | ChEBI | Al | ChEBI | Aluminio | ChEBI | Aluminium | ChEBI | Aluminium-27 | HMDB | Aluminium 27 | HMDB | Aluminum 27 | HMDB | Aluminum-27 | HMDB | Aluminum | ChEBI |
|
---|
Chemical Formula | Al |
---|
Average Molecular Weight | 26.9815 |
---|
Monoisotopic Molecular Weight | 26.981538441 |
---|
IUPAC Name | alumane |
---|
Traditional Name | alumane |
---|
CAS Registry Number | 7429-90-5 |
---|
SMILES | [Al] |
---|
InChI Identifier | InChI=1S/Al |
---|
InChI Key | XAGFODPZIPBFFR-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of inorganic compounds known as homogeneous post-transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a post-transition metal atom. |
---|
Kingdom | Inorganic compounds |
---|
Super Class | Homogeneous metal compounds |
---|
Class | Homogeneous post-transition metal compounds |
---|
Sub Class | Not Available |
---|
Direct Parent | Homogeneous post-transition metal compounds |
---|
Alternative Parents | Not Available |
---|
Substituents | - Homogeneous post-transition metal
|
---|
Molecular Framework | Not Available |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Biological locationSourceExogenousFoodVegetableNutFruitCereal and cereal productPulseSoyHerb and spiceGourdMilk and milk productUnfermented milk- Milk (Cow) (FooDB: FOOD00618)
- Cow milk, pasteurized, vitamin A + D added, 2% fat (FooDB: FOOD00891)
- Cow milk, pasteurized, vitamin A + D added, 0% fat (FooDB: FOOD00889)
- Cow milk, pasteurized, vitamin A + D added, 1% fat (FooDB: FOOD00890)
- Cow milk, pasteurized, vitamin D added, 3.25% fat (FooDB: FOOD00892)
TeaAquatic origin |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 660 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
Aluminum | [Al] | 708.3 | Standard polar | 33892256 | Aluminum | [Al] | 233.6 | Standard non polar | 33892256 | Aluminum | [Al] | 74.6 | Semi standard non polar | 33892256 |
|
---|
Spectra |
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aluminum 10V, Positive-QTOF | splash10-001i-9000000000-9378da25f3a524cf38e8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aluminum 20V, Positive-QTOF | splash10-001i-9000000000-9378da25f3a524cf38e8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aluminum 40V, Positive-QTOF | splash10-001i-9000000000-9378da25f3a524cf38e8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aluminum 10V, Negative-QTOF | splash10-001i-9000000000-71051ebfdb9ee6a6ce2d | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aluminum 20V, Negative-QTOF | splash10-001i-9000000000-71051ebfdb9ee6a6ce2d | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aluminum 40V, Negative-QTOF | splash10-001i-9000000000-71051ebfdb9ee6a6ce2d | 2016-08-04 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.1 +/- 0.056 uM | Elderly (>65 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.185 (0.019-0.482) uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.037-0.410 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 109 +/- 26 uM | Adult (>18 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 12.1+/-6.33 (7.4-25.9) uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 228.08 +/- 71.18 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.0515 +/- 0.0315 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.474 +/- 0.252 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.236 +/- 0.265 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.231 +/- 0.311 uM | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.31 (0.05-1.21) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | <0.14650 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.667 +/- 0.037 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.024 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.89 +/- 0.79 uM | Adult (>18 years old) | Both | Multiple sclerosis | | details | Blood | Detected and Quantified | 0.11 +/- 0.00061 uM | Adult (>18 years old) | Both | Parkinson's disease | | details | Blood | Detected and Quantified | 0.0823 +/- 0.0460 uM | Elderly (>65 years old) | Both | Alzheimer's disease | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Alzheimer's disease |
---|
- Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203. [PubMed:16244393 ]
| Multiple sclerosis |
---|
- Forte G, Visconti A, Santucci S, Ghazaryan A, Figa-Talamanca L, Cannoni S, Bocca B, Pino A, Violante N, Alimonti A, Salvetti M, Ristori G: Quantification of chemical elements in blood of patients affected by multiple sclerosis. Ann Ist Super Sanita. 2005;41(2):213-6. [PubMed:16244395 ]
| Parkinson's disease |
---|
- Forte G, Alimonti A, Pino A, Stanzione P, Brescianini S, Brusa L, Sancesario G, Violante N, Bocca B: Metals and oxidative stress in patients with Parkinson's disease. Ann Ist Super Sanita. 2005;41(2):189-95. [PubMed:16244392 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB01370 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB003570 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4514248 |
---|
KEGG Compound ID | C06264 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Aluminium |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5359268 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 28984 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00000310 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Kang, B. S.; Kim, W. B.; Park, Y. S.; Yoo, Y. H. Recovery of aluminum from anthracite ash. Konghak Nonjip (1989), 30 57-70. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Strunecka A, Strunecky O, Patocka J: Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information. Physiol Res. 2002;51(6):557-64. [PubMed:12511178 ]
- Elmore AR: Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. Int J Toxicol. 2003;22 Suppl 1:37-102. [PubMed:12851164 ]
- Savory J, Herman MM, Ghribi O: Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem. 2003 Sep 15;97(1):151-4. [PubMed:14507471 ]
- Arnold CJ, Miller GG, Zello GA: Parenteral nutrition-associated cholestasis in neonates: the role of aluminum. Nutr Rev. 2003 Sep;61(9):306-10. [PubMed:14552065 ]
- Zatta P, Lucchini R, van Rensburg SJ, Taylor A: The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull. 2003 Nov 15;62(1):15-28. [PubMed:14596888 ]
- Gherardi RK, Authier FJ: Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am. 2003 Nov;23(4):699-712. [PubMed:14753387 ]
- Becaria A, Campbell A, Bondy SC: Aluminum as a toxicant. Toxicol Ind Health. 2002 Aug;18(7):309-20. [PubMed:15068131 ]
- Klein GL: Aluminum: new recognition of an old problem. Curr Opin Pharmacol. 2005 Dec;5(6):637-40. Epub 2005 Sep 28. [PubMed:16198633 ]
- Kawahara M: Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis. 2005 Nov;8(2):171-82; discussion 209-15. [PubMed:16308486 ]
- Aremu DA, Meshitsuka S: Some aspects of astroglial functions and aluminum implications for neurodegeneration. Brain Res Rev. 2006 Aug 30;52(1):193-200. Epub 2006 Mar 10. [PubMed:16529821 ]
- Perl DP, Moalem S: Aluminum and Alzheimer's disease, a personal perspective after 25 years. J Alzheimers Dis. 2006;9(3 Suppl):291-300. [PubMed:17004365 ]
- Savory J, Herman MM, Ghribi O: Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease. J Alzheimers Dis. 2006 Nov;10(2-3):135-44. [PubMed:17119283 ]
- Campbell A: The role of aluminum and copper on neuroinflammation and Alzheimer's disease. J Alzheimers Dis. 2006 Nov;10(2-3):165-72. [PubMed:17119285 ]
- Miu AC, Benga O: Aluminum and Alzheimer's disease: a new look. J Alzheimers Dis. 2006 Nov;10(2-3):179-201. [PubMed:17119287 ]
- Yokel RA: Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis. 2006 Nov;10(2-3):223-53. [PubMed:17119290 ]
- Domingo JL: Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. J Alzheimers Dis. 2006 Nov;10(2-3):331-41. [PubMed:17119296 ]
- Riggs K, Keller M, Humphreys TR: Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet. Clin Dermatol. 2007 Sep-Oct;25(5):462-73. [PubMed:17870524 ]
- Hem SL, Hogenesch H: Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev Vaccines. 2007 Oct;6(5):685-98. [PubMed:17931150 ]
- Nokleby H: Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine. Expert Rev Vaccines. 2007 Oct;6(5):863-9. [PubMed:17931164 ]
|
---|